NO2855624T3 - - Google Patents

Info

Publication number
NO2855624T3
NO2855624T3 NO13728296A NO13728296A NO2855624T3 NO 2855624 T3 NO2855624 T3 NO 2855624T3 NO 13728296 A NO13728296 A NO 13728296A NO 13728296 A NO13728296 A NO 13728296A NO 2855624 T3 NO2855624 T3 NO 2855624T3
Authority
NO
Norway
Application number
NO13728296A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2855624T3 publication Critical patent/NO2855624T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C12N2310/141—MicroRNAs, miRNAs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/30—Special therapeutic applications
    • C12N2320/32—Special delivery means, e.g. tissue-specific
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00—Production
    • C12N2330/50—Biochemical production, i.e. in a transformed host cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO13728296A 2011-12-13 2013-05-31 NO2855624T3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161570081P 2011-12-13 2011-12-13

Publications (1)

Publication Number Publication Date
NO2855624T3 true NO2855624T3 (fr) 2018-04-14

Family

ID=47470222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO13728296A NO2855624T3 (fr) 2011-12-13 2013-05-31

Country Status (7)

Country Link
US (1) US9555060B2 (fr)
EP (2) EP3336190B1 (fr)
DK (1) DK2791336T3 (fr)
ES (1) ES2661236T3 (fr)
NO (1) NO2855624T3 (fr)
TR (1) TR201802778T4 (fr)
WO (1) WO2013090523A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227593B2 (en) 2011-12-13 2019-03-12 Henry Ford Health System Methods, systems, and compositions for cell-derived/vesicle-based microRNA delivery
US10308959B2 (en) 2013-01-18 2019-06-04 Henry Ford Health System Methods, systems, and compositions relating to MiRNA-146a
WO2016179417A2 (fr) * 2015-05-06 2016-11-10 The University Of Utah Research Foundation Administration d'exosomes de micro-arn
US11040071B2 (en) 2015-10-13 2021-06-22 Cells For Cells S.A. Anti-angiogenic therapy based on exosomes derived from menstrual stem cells
KR20180086440A (ko) 2015-11-18 2018-07-31 유니버시티 오브 조지아 리서치 파운데이션, 인코포레이티드 신경 세포 세포외 소포체
US11821036B2 (en) * 2017-03-16 2023-11-21 Ramot At Tel-Aviv University Ltd. Methods for identifying and monitoring pregnant women at risk of preeclampsia
KR20200034668A (ko) 2017-05-08 2020-03-31 플래그쉽 파이어니어링 이노베이션스 브이, 인크. 막 융합을 촉진시키기 위한 조성물 및 그의 용도
AU2021344607A1 (en) 2020-09-21 2023-06-01 Asklepios Biopharmaceutical, Inc. Methods for treating neurological disease
WO2023240069A1 (fr) * 2022-06-06 2023-12-14 The University Of Vermont And State Agricultural College Microarn de vésicules extracellulaires et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9085778B2 (en) * 2006-05-03 2015-07-21 VL27, Inc. Exosome transfer of nucleic acids to cells
US20110177054A1 (en) * 2008-06-06 2011-07-21 Derrick Gibbings Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
ES2749393T3 (es) * 2009-04-17 2020-03-20 Univ Oxford Innovation Ltd Composición para entrega de material genético

Also Published As

Publication number Publication date
EP2791336A2 (fr) 2014-10-22
DK2791336T3 (en) 2018-02-26
WO2013090523A2 (fr) 2013-06-20
WO2013090523A3 (fr) 2013-08-22
US9555060B2 (en) 2017-01-31
EP3336190A1 (fr) 2018-06-20
EP3336190B1 (fr) 2021-02-24
ES2661236T3 (es) 2018-03-28
US20150157666A1 (en) 2015-06-11
EP2791336B1 (fr) 2017-11-29
TR201802778T4 (tr) 2018-03-21

Similar Documents

Publication Publication Date Title
BR112013022641A2 (fr)
AP3853A (fr)
BR112013024383A2 (fr)
BR112013023185A2 (fr)
BR112013022995A2 (fr)
BR112013017670A2 (fr)
BR112013024365A2 (fr)
BR112013028733A2 (fr)
AP2016009466A0 (fr)
BR112013024588A2 (fr)
BR112013032380A2 (fr)
BR112013032377A2 (fr)
BR112013032368A2 (fr)
BR112013018949A2 (fr)
BR112013021637A2 (fr)
BR112013023266A2 (fr)
BR112013032392A2 (fr)
BR112013025487A2 (fr)
BR112013017878A2 (fr)
NO2855624T3 (fr)
BR112013032394A2 (fr)
BR112013030734A2 (fr)
BR112013022499A2 (fr)
AP3777A (fr)
BR102012019800A2 (fr)